Table 2.
Item | Positive rate (%) | No. of cases | Author |
---|---|---|---|
WBC >10 000/mm3 | 79 | 449 | Gigot12 |
63 | 78 | Saharia17 | |
82 | 71 | Boey13 | |
Total bilirubin ↑ | 91 | 78 | Saharia17 |
78 | 74 | Boey13 | |
ALP ↑ | 93 | 449 | Gigot JF5 |
92 | 72 | Saharia17 | |
74 | 74 | Boey13 | |
AST ↑ | 93 | 45 | Saharia17 |
ALT ↑ | 97 | 35 | Saharia17 |
AST or ALT ↑ | 57 | 74 | Boey13 |
Prolonged prothrombin time | 26 | 74 | Boey13 |
Amylase ↑ | 7 | 74 | Boey13 |
35 | 54 | Boey13 | |
Creatinine ≧1.5 mg/d | 16 | 125 | Tai5 |
CA19-9 ↑ | 28 | 25 | Ker19 |
100 | 7 | Albert20 | |
Endotoxin ↑ | 36 | 11 | Kanazawa21 |
WBC, white blood cells; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CA 19–9, carbohydrate antigen 19–9